Annual report pursuant to Section 13 and 15(d)

Nature of Operations, Business Activities and Summary of Significant Accounting Policies (Detail Textuals)

v3.7.0.1
Nature of Operations, Business Activities and Summary of Significant Accounting Policies (Detail Textuals)
 1 Months Ended 12 Months Ended
Oct. 31, 2014
shares
Dec. 31, 2016
USD ($)
Segment
$ / shares
shares
Dec. 31, 2015
USD ($)
$ / shares
shares
Jan. 31, 2017
USD ($)
Dec. 31, 2014
USD ($)
Nature of Operations, Business Activities and Summary of Significant Accounting Policies [Line Items]          
Cash and cash equivalents | $   $ 64,820 $ 3,221,209   $ 207,330
Restricted cash | $   37,500 37,500    
Property and equipment, net | $   $ 9,584 $ 13,383    
Property, plant and equipment, depreciation methods   Straight-line method      
Property plant and equipment estimated useful life   Two to three years      
Number of reportable segment | Segment   1      
Common stock outstanding   21,563,163 19,903,163    
Subsequent Event          
Nature of Operations, Business Activities and Summary of Significant Accounting Policies [Line Items]          
Additional fund operations raised | $       $ 1,200,000  
Series B Preferred Stock          
Nature of Operations, Business Activities and Summary of Significant Accounting Policies [Line Items]          
Anti-dilutive excluded from the calculation of diluted loss per common share   4,031 4,500    
Preferred stock shares convertible into common stock   16,124,000 5,625,000    
Preferred stock, convertible price per share | $ / shares   $ 0.25 $ 0.80    
Series C Preferred Stock          
Nature of Operations, Business Activities and Summary of Significant Accounting Policies [Line Items]          
Anti-dilutive excluded from the calculation of diluted loss per common share   386      
Preferred stock shares convertible into common stock   1,544,000      
Preferred stock, convertible price per share | $ / shares   $ 0.25      
Warrants          
Nature of Operations, Business Activities and Summary of Significant Accounting Policies [Line Items]          
Anti-dilutive excluded from the calculation of diluted loss per common share   11,044,500 10,879,500    
Stock Option          
Nature of Operations, Business Activities and Summary of Significant Accounting Policies [Line Items]          
Anti-dilutive excluded from the calculation of diluted loss per common share   1,142,500 1,180,000    
Nemus Acquisition Corp          
Nature of Operations, Business Activities and Summary of Significant Accounting Policies [Line Items]          
Number of shares exchanged 12,880,000        
Common stock outstanding 16,000,000        
Nemus Acquisition Corp | Nemus Bioscience, Inc          
Nature of Operations, Business Activities and Summary of Significant Accounting Policies [Line Items]          
Reverse merger common stock issuance with par value (in shares) 3,120,000